Ventricular arrhythmias in patients treated with methadone for opioid dependence

Journal of Interventional Cardiac Electrophysiology

Volumn 28, Issue 1, 2010, Pages 19-22

  Hanon, Sam ^a   Seewald, Randy M ^a   Yang, Felix ^a   Schweitzer, Paul ^a   Rosman, Jonathan ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Buprenorphine; Methadone; Torsades de Pointes; Ventricular arrhythmias

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; ISOPRENALINE; MAGNESIUM; METHADONE; MORPHINE;

ADULT; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DEFIBRILLATOR; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RECURRENT DISEASE; SURVIVAL; TORSADE DES POINTES; WITHDRAWAL SYNDROME;

ADULT; CARDIAC PACING, ARTIFICIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG QT SYNDROME; MALE; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TORSADES DE POINTES; TREATMENT OUTCOME;

EID: 77954956046     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-009-9465-9     Document Type: Article

References (18)

1. Fiellin, D. A., & O'Connor, P. G. (2002). Office-based treatment of opioid-dependent patients. NEJM, 347, 817-823.
2. Roden, D. M. (2004). Drug-induced prolongation of the QT interval. NEJM, 350, 1013-1022.
3. Esses, J., Rosman, J., Do, L., & Hanon, S. (2008). Successful transition to buprenorphine in a patient with methadone induced Torsades de Pointes. J Interv Card Electrophysiol, 23, 117-119.
4. Wedam, E. F., Bigelow, G. E., Johnson, R. E., Nuzzo, P. A., & Haigney, M. C. P. (2007). QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Archives of Internal Medicine, 167, 2469-2473.
5. Ehret, G. B., Voide, C., Gex-Fabry, M., Chabert, J., Shah, D., Broers, B., et al. (2006). Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Archives of Internal Medicine, 166, 1280-1287.
6. Byrne, A., & Stimmel, B. (2007).Methadone and QTc prolongation. Lancet, 369, 366.
7. Justo, D., Gal-Oz, A., Paran, Y., Goldin, Y., & Zeltser, D. (2006). Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients. Addiction, 101, 1333-1338.
8. Pearson, E. C., & Woosley, R. L. (2005). QT prolongation and Torsades de Pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiology and Drug Safety, 14, 747-753.
9. Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002). Torsade de Pointes associated with very-high-dose methadone. Annals of Internal Medicine, 137, 501-504.
10. Fanoe, S., Hvidt, C., Ege, P., & Jensen, G. B. (2007). Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart, 93, 1051-1055.
11. Chugh, S. S., Socoteanu, C., Reinier, K., Waltz, J., Jui, J., & Gunson, K. (2008). A community-based evaluation of sudden death associated with therapeutic levels of methadone. American Journal of Medicine, 121, 66-71.
12. Patel, A. M., Singh, J. P., & Ruskin, J. N. (2008). Role of implantable cardioverter-defibrillators in patients with methadoneinduced long QT syndrome. American Journal of Cardiology, 101, 209-211.
13. Hubbard, R. L., Craddock, S. G., Flynn, P. M., & Anderson, J. (1997). Etheridge RM overview of 1-year follow-up outcomes in drug abuse treatment outcome study. Psychology of Addictive Behaviors, 11, 261-278. (Pubitemid 28046589)
14. Regarding Methadone Treatment. New York State Committee of Methadone Program Administrators (COMPA). 1997, pp 6-10.
15. Johnson, R. E., Jaffe, J. H., & Fudala, P. J. (1992). A controlled trial of buprenorphine treatment for opioid dependence. JAMA, 267, 2750-2755.
16. Helm, S., Trescot, A. M., Colson, J., Sehgal, N., & Silverman, S. (2008). Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification. Pain Physician, 11, 225-235.
17. Ancherson, K., Clausen, T., Gossop, M., Hasnteen, V., & Waal, H. (2009). Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction, 104, 993-999.
18. Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioiddependent patients. Addiction, 98, 441-452.